Arterial Hypertension as a Risk Comorbidity Associated with COVID-19 Pathology.

Authors:
Kamyshnyi A; Krynytska I; Matskevych V; Marushchak M; Lushchak O.

Journal:
Int J Hypertens

Publication Year: 2020

DOI:
10.1155/2020/8019360

PMCID:
PMC7803108

PMID:
33489355

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Int J Hypertens

Abbreviation: Int J Hypertens

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Peripheral Vascular Disease

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Da-Chuan-Xiong Decoction Ameliorates Sodium Sensitivity and Plasma Norepinephrine via Attenuation o…
Zhang Q; Li H; Zhao S and 2 more (2024) - Transparency Score: 3/6
Lipid Horizons: Recent Advances and Future Prospects in LBDDS for Oral Administration of Antihypert…
Preeti; Sambhakar S; Malik R and 7 more (2024) - Transparency Score: 2/6
Comorbidity of Anxiety and Hypertension: Common Risk Factors and Potential Mechanisms.
Qiu T; Jiang Z; Chen X and 2 more (2023) - Transparency Score: 3/6
Efficacy and Safety of Eplerenone for Treating Chronic Kidney Disease: A Meta-Analysis.
Hu H; Cao M; Sun Y and 3 more (2023) - Transparency Score: 3/6
Evaluation of Arterial Stiffness and Its Relation to Innovative Anthropometric Indices in Persian A…
Ataee Z; Aghaee A; Sobhani SR and 5 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest The authors declare that they have no conflicts of interest."

Evidence found in paper:

"This work was partially supported by a grant from National Science Foundation of Ukraine (#2020.01/0157)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025